Cargando…
Luoyutong Treatment Promotes Functional Recovery and Neuronal Plasticity after Cerebral Ischemia-Reperfusion Injury in Rats
Luoyutong (LYT) capsule has been used to treat cerebrovascular diseases clinically in China and is now patented and approved by the State Food and Drug Administration. In this retrospective validation study we investigated the ability of LYT to protect against cerebral ischemia-reperfusion injury in...
Autores principales: | Wang, Ning-qun, Wang, Li-ye, Zhao, Hai-ping, Liu, Ping, Wang, Rong-liang, Song, Jue-xian, Gao, Li, Ji, Xun-ming, Luo, Yu-min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678236/ https://www.ncbi.nlm.nih.gov/pubmed/26697095 http://dx.doi.org/10.1155/2015/369021 |
Ejemplares similares
-
Circ-camk4 involved in cerebral ischemia/reperfusion induced neuronal injury
por: Zhang, Zhao-huan, et al.
Publicado: (2020) -
ESE1 expression correlates with neuronal apoptosis in the hippocampus after cerebral ischemia/reperfusion injury
por: Yu, Hai-Long, et al.
Publicado: (2019) -
Neuroprotective effects of SMADs in a rat model of cerebral ischemia/reperfusion
por: Liu, Fang-fang, et al.
Publicado: (2015) -
Mastoparan M extracted from Vespa magnifica alleviates neuronal death in global cerebral ischemia-reperfusion rat model
por: Wang, Mei, et al.
Publicado: (2022) -
Dual antiplatelet therapy improves functional recovery and inhibits inflammation after cerebral ischemia/reperfusion injury
por: Dong, Wen, et al.
Publicado: (2022)